Key result
Percutaneous transluminal coronary angioplasty in male patients over 70 years old demonstrated high procedural success, with an in-hospital MACE rate of 8.82% and a 1-year MACE rate of 17.64%.
Why the study?
PTCA is increasingly recognized for revascularization in older patients, who face higher postoperative mortality and complications with bypass surgery, motivating analysis of its therapeutic efficacy in individuals above 70 years.
What are the procedural success rates and MACE incidences following PTCA in male patients over 70 years?
Observational (n=102)
No
What are the procedural success rates and MACE incidences following PTCA in male patients over 70 years?
PTCA in elderly male patients (>70 years) demonstrates high procedural success, particularly in single and double vessel disease, with acceptable MACE rates up to 1 year.
Supports PCI consideration in select patients over 70; leaves open need for randomized confirmation of efficacy.
Background: Even in older patients, percutaneous transluminal coronary angioplasty (PTCA) is becoming a more widely acknowledged technique for revascularization. Because to its less intrusive nature, PTCA is a desirable option to coronary bypass surgery in this age category due to the increased frequency of postoperative mortality and treatment problems in older patients. Objective: Analyze the immediate and ongoing therapeutic efficacy of PTCA in individuals above 70 years. Methods: In the Hayatabad Medical Complex hospital in Peshawar, 6830 patients had PCI between April 2021 and August 2022. Throughout the trial period, interventions were performed on 102 male patients who were above 70 years. Results: Among the 102 patients, Thirty-two patients (31.37% of the total) had left ventricular ejection fraction (LVEF) lower than 40%. One hundred percent of patients with single vessel disease (SVD), 94 % and 72 % of participants with double vessel disease and triple vessel disease (TVD), respectively had successful procedures. The rate of major adverse cardiac event (MACE) in hospitals was 9/102 (8.82%). The 1-month MACE incidence was 10.78% (n=11) while the one-year MACE incidence was 17.64% (n=18), correspondingly.
No takes yet. Share an insight, caveat, or question.
Zeb et al. (2023) conducted an observational in Coronary artery disease (n=102). Percutaneous transluminal coronary angioplasty (PTCA) was evaluated on In-hospital Major Adverse Cardiac Event (MACE). Percutaneous transluminal coronary angioplasty in male patients over 70 years old demonstrated high procedural success, with an in-hospital MACE rate of 8.82% and a 1-year MACE rate of 17.64%.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: